{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:22:57Z","timestamp":1781511777617,"version":"3.54.1"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jcv.2016.12.005","type":"journal-article","created":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T18:16:31Z","timestamp":1481739391000},"page":"17-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Progressive multifocal leukoencephalopathy in a patient with systemic mastocytosis treated with cladribine"],"prefix":"10.1016","volume":"88","author":[{"given":"Karl B.","family":"Alstadhaug","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randi","family":"Fykse Halstensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Odeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2016.12.005_bib0005","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1182\/blood-2014-12-614743","article-title":"Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis","volume":"126","author":"Barete","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jcv.2016.12.005_bib0010","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/ejh.12544","article-title":"Current treatment options in patients with mastocytosis: status in 2015 and future perspectives","volume":"94","author":"Arock","year":"2015","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.jcv.2016.12.005_bib0015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/10428199909169620","article-title":"Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment","volume":"35","author":"Bastie","year":"1999","journal-title":"Leukemia Lymphoma"},{"key":"10.1016\/j.jcv.2016.12.005_bib0020","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/jamaneurol.2014.825","article-title":"Treatment of progressive multifocal leukoencephalopathy with interleukin 7","volume":"71","author":"Alstadhaug","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jcv.2016.12.005_bib0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1517\/14656566.2013.754012","article-title":"Cladribine tablets for the treatment of relapsing-remitting multiple sclerosis","volume":"14","author":"Comi","year":"2013","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.jcv.2016.12.005_bib0030","unstructured":"Merck. Merck Receives European Medicines Agency Acceptance for Review of Marketing Authorization Application for Cladribine Tablets. 2016 (Accessed 4 November 2016)."},{"key":"10.1016\/j.jcv.2016.12.005_bib0035","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(10)70040-5","article-title":"Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis","volume":"9","author":"Tan","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jcv.2016.12.005_bib0040","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jcv.2016.12.005_bib0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1189\/jlb.5RU0614-296R","article-title":"The immunophenotype of mast cells and its utility in the diagnostic work-up of systemic mastocytosis","volume":"97","author":"Teodosio","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jcv.2016.12.005_bib0050","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"Valent","year":"2007","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.jcv.2016.12.005_bib0055","first-page":"A28","article-title":"Progressive multifocal leukoencephalopathy after cladribine treatment for hairy cell leukemia","volume":"76","author":"Aletti","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jcv.2016.12.005_bib0060","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3109\/10428194.2012.740669","article-title":"Development of progressive multifocal leukoencephalopathy in a patient with non-Hodgkin lymphoma 13 years after treatment with cladribine","volume":"54","author":"Berghoff","year":"2013","journal-title":"Leukemia Lymphoma"},{"key":"10.1016\/j.jcv.2016.12.005_bib0065","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.humimm.2016.01.016","article-title":"CD4HLA-G regulatory T cells: molecular signature and pathophysiological relevance","volume":"77","author":"Pankratz","year":"2016","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jcv.2016.12.005_bib0070","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3389\/fimmu.2015.00604","article-title":"Involvement of CD8(+) t cells in multiple sclerosis","volume":"6","author":"Salou","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jcv.2016.12.005_bib0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jcv.2016.03.003","article-title":"A case of relapsing-remitting facial palsy and ipsilateral brachial plexopathy caused by HSV-1","volume":"78","author":"Alstadhaug","year":"2016","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2016.12.005_bib0080","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJMoa051847","article-title":"Progressive multifocal leukoencephalopathy in a patient treated with natalizumab","volume":"353","author":"Langer-Gould","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2016.12.005_bib0085","doi-asserted-by":"crossref","unstructured":"E.M. Williamson, J.R. Berger, Central Nervous System Infections With Immunomodulatory Therapies. Continuum (Minneapolis, Minn) (2015) 21, 1577\u20131598.","DOI":"10.1212\/CON.0000000000000245"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653216306187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653216306187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T01:22:23Z","timestamp":1536196943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653216306187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":17,"alternative-id":["S1386653216306187"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2016.12.005","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progressive multifocal leukoencephalopathy in a patient with systemic mastocytosis treated with cladribine","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2016.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}